Bristol-Myers Squibb Company
Utility Patent Applications
Last updated:
List of all Bristol-Myers Squibb Company patents 438 in total
| Status | Patent |
|---|---|
Application | Utility: PYRIMIDINE CARBOXAMIDES AS GSK-3 INHIBITORS Filling date: 6 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: USE OF PHENOLIC ANTIOXIDANTS IN CELL BIOPRODUCTION Filling date: 6 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: IMMUNOMODULATORS ACTING AS ANTAGONISTS OF PD-1 Filling date: 6 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: INDOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: FIVE MEMBERED-AMINOHETEROCYCLE AND 5,6-or 6,6-MEMBERED BICYCLIC AMINOHETEROCYCLIC INHIBITORS OF ROCK FOR THE TREATMENT OF HEART FAILURE Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH Filling date: 6 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: STABLE FORMULATIONS OF FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: SUBSTITUTED QUINOLINYLCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: SUBSTITUTED NITROGEN CONTAINING COMPOUNDS Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHE- NYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: DESIGN OF THERAPEUTIC IMMUNOGLOBULIN G4 FOR IMPROVED BIOANALYTICAL AND BIOPROCESSING PROPERTIES Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: PROCESS FOR PREPARING TETRAHYDROCARBAZOLE CARBOXAMIDE COMPOUND Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: 4-AZAINDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: TETRAZOLONE-SUBSTITUTED DIHYDROPYRIDINONE MGAT2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING HETEROATOM-LINKED AROMATIC MOIETIES, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS OF TREATING EARLY RHEUMATOID ARTHRITIS Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS FOR TREATING COSTIMULATION BLOCKADE RESISTANT REJECTION Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: THIENOPYRIDINES AND BENZOTHIOPHENES USEFUL AS IRAK4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: A SUPRAMOLECULAR HIGH AFFINITY PROTEIN-BINDING SYSTEM FOR PURIFICATION OF BIOMACROMOLECULES Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: PYRIMIDINONES AS FACTOR XIA INHIBITORS Filling date: 6 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A PYRIDINE OR PYRAZINE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A HETEROBIARYL MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: ACYL SULFONAMIDE NAV1.7 INHIBITORS Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Showing 300 to 350 of 438 patents.